Hyderabad: A team of experts from Central Drugs Standard Control Organisation (CDSCO), the regulatory body of Indian pharmaceuticals and medical devices, is expected to visit MGM Hospital in Warangal on Tuesday to interact with Boga Suresh, the patient who got sick sick after taking part in clinical trials, conducted by Bengaluru-based pharmaceutical companies.
Following the incident in which three persons, all hailing from Jammikunta area in Karimnagar, displayed adverse reactions after participating in drugs trials, the State government on its part had alerted CDSCO for further action.
In the coming days, a special team of experts from CDSCO are expected to arrive and interact with patients and their relatives in Jammikunta. Officials here are anticipating that a Central team is also expected to visit MGM Hospital in Warangal.
Recently, in order to avoid instances of extreme adverse reactions to clinical trials and to have a proper system to track persons who volunteer for clinical trials, the State Government had mooted the idea of Aadhar-based unique registration for participation in clinical trials in the entire country.
“This system of Aadhar based registration system will enable us to keep a close tab of persons who are volunteering to take part in clinical trials. The CDSCO is yet to take a call on this proposal,” health officials here said.